Is Barclays plc a buy after Q3 results?

Barclays plc (LON: BARC) has finally completed its mammoth restructuring. Is the re-forged operation a buy after Q3 results?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The Barclays (LSE: BARC) Q3 results were described as “particularly significant” by CEO Jes Staley because they represent the first period since the company completed a disruptive restructuring programme that included closing its Non-Core unit and the disposal of Barclays Africa. 

The strategy has been simple – sell off these underperforming assets so that the company’s stronger divisions, including the UK retail bank and its Consumer, Cards and Payments division, could shine. 

The transition has been painful for shareholders. The shares are down 26% in two years and the dividend was cut in half last year. Now that the CEO describes the business as “the bank we want to be,” the pressure is on to meet its goals to deliver a 10% return on tangible equity (ROTE) by 2020.

A better Barclays?

Anyone buying Barclays shares over the last few years has had both eyes firmly on the future, so the big question remains: will the restructured Barclays see significantly improved performance now it has emerged from this turbulent period? 

After the disposal of its African business, the company’s CET1 stands at 13.1%, which is pretty much bang on its targeted long-term capitalisation level. So far so good. 

Barclays UK and Barclays International delivered ROTE of 9.4% and 10% respectively in the quarter, but the group total came in at a sub-par 7.1%, a decline from the first half’s 8% figure. This figure excludes the loss on the sale of Barclay’s Africa Group, charges for PPI and impairment charges but these seem fair and consistent adjustments that help us understand how the ongoing operation is truly functioning. 

Profit from continuing operations was up a solid 26% this quarter, although this was driven by a significant reduction in operating costs rather than top-line growth and was held back by a poor showing from the Corporate & Investment Bank, with income falling 5%, driven largely by a 14% fall in income from the markets division.  

Perhaps we shouldn’t be too harsh on the Investment Bank given its recent resurgence despite the difficult macro environment, yet there’s no denying quarters like this are bad news for Staley’s long-term strategy, which depends on a large improvement in the division’s performance.  

Fears baked into the price

Net tangible asset value per share as of 30 August was 281p, compared to a share price of only 184p today. That’s a strikingly cheap valuation, but there is significant uncertainty hanging over the bank including claims that Staley attempted to track down a whistleblower, a pension deficit and various troubling macro factors including Brexit. 

In all, I’m not certain that Barclays is going to be a wonderful long-term investment but I do believe it is likely looking too cheap right now. The dividend yield is a poor 1.6% but an investment in it should surely be based on the 35% discount to net tangible assets.

It certainly has the value investor in me excited but I’m not sold on the strategy to beef up the investment bank, nor am I an expert in the banking sector. Despite that, I’m still tempted to buy a small speculative position in the company and believe Barclays could make an excellent investment for the more risk-hungry Fools out there. 

Zach Coffell has no position in any shares mentioned. The Motley Fool UK has recommended Barclays. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »